Radiobiological effects often depend on dose rate but to a greater or lesser extent according to the actual level of the dose rate and the nature of the effect (Hall, 1978) . For example, it is generally observed for mammalian cells irradiated in vitro that for dose rates larger than about 1 Gy·min-1 survival is independent of dose rate, but becomes increasingly dependent on dose rate at lower rates. For dose rates below about 1 Gy·h-1 survival again becomes independent of dose rate.
The relationship between dose rate and tissue response in vivo is complex because many factors have to be taken into account such as cell distribution, repair of potentially lethal lesions, and, for tumors, reoxygenation. As far as cell proliferation is concerned, its role is probably a minor one in brachytherapy applications.
In each brachytherapy application, there is necessarily both a marked dose gradient and a marked dose rate gradient as a function of distance from the sources.
The possible importance of changes in time factors (dose rate) in determining the biological or clinical effect should not be underestimated since there may be a shell of tissues surrounding the sources where differences in 15 dose rate may be significant (Van Limbergen et al., 1985) . Its location and thickness will vary with the total reference air kerma rate and the application time. In addition, the time between fractions is important in the case of fractionated high dose-rate intracavitary therapy.
It can be concluded that any significant change in the source strength and the time-dose pattern should be made with the greatest care. Furthermore, early tissue reactions alone should not be used to select the prescribed dose since late reactions, which are most relevant, depend to a greater extent on dose rate.
Recommendations for Reporting Time-Dose
Pattern Sufficient data on the effect of dose-rate on various tissues are not available at the present time. Therefore, no correction factors for dose rate can be recommended, but the duration of the application should be stated.
When more than one application is performed, the duration of each should be reported, as well as the time interval(s) between them.
Similarly, when external beam therapy and intracavitary therapy are combined, the time-dose schedule of the whole treatment should be reported.
